Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5092449
Max Phase: Preclinical
Molecular Formula: C43H69N11O9
Molecular Weight: 884.09
Molecule Type: Unknown
Associated Items:
ID: ALA5092449
Max Phase: Preclinical
Molecular Formula: C43H69N11O9
Molecular Weight: 884.09
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C43H69N11O9/c1-24(2)21-31(37(57)48-26(5)35(55)50-30(42(62)63)15-10-18-47-43(45)46)51-38(58)34-17-12-20-54(34)41(61)32(22-25(3)4)52-39(59)33-16-11-19-53(33)40(60)27(6)49-36(56)29(44)23-28-13-8-7-9-14-28/h7-9,13-14,24-27,29-34H,10-12,15-23,44H2,1-6H3,(H,48,57)(H,49,56)(H,50,55)(H,51,58)(H,52,59)(H,62,63)(H4,45,46,47)/t26-,27+,29+,30+,31+,32+,33+,34+/m1/s1
Standard InChI Key: LDJTYBMZDFFZQK-NKYAFPQCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 884.09 | Molecular Weight (Monoisotopic): 883.5280 | AlogP: -0.56 | #Rotatable Bonds: 23 |
Polar Surface Area: 311.34 | Molecular Species: ZWITTERION | HBA: 10 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 20 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.94 | CX Basic pKa: 11.62 | CX LogP: -2.19 | CX LogD: -2.66 |
Aromatic Rings: 1 | Heavy Atoms: 63 | QED Weighted: 0.04 | Np Likeness Score: -0.04 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):